Bicara Therapeutics Inc. 4

Jeremy Bender received a stock option award for 38,950 shares of Bicara Therapeutics Inc. common stock at a $26.88 exercise price.

On July 28, 2026, Jeremy Bender, an insider of Bicara Therapeutics Inc., received a stock option grant for 38,950 shares of common stock at an exercise price of $26.88 per share, with one-third of the option vesting on July 28, 2027 and the remainder vesting in 24 equal monthly installments thereafter, contingent on his continued service. This is a compensatory award rather than an open-market transaction and results in Bender having derivative rights over 38,950 shares following the grant; the Form 4 does not disclose his total non-derivative common stock holdings. Based on the exercise price as a proxy for current value, the option grant represents an implied notional value of approximately $1,047,216, though the actual realizable value depends on future stock performance.

Filing Facts

CIK

2023658

Ticker

BCAX

Form

4

Source Type

fda

Accession

0001470831-26-000738

Alert Tier

6